Pathological complete response: still a relevant endpoint in rectal cancer?

被引：14

作者：

Chua, Yu Jo ^{[1
]}

机构：

[1] Canberra Hosp, Med Oncol Unit, Woden, ACT 2606, Australia

来源：

LANCET ONCOLOGY | 2010年 / 11卷 / 09期

关键词：

TRIAL;

D O I：

10.1016/S1470-2045(10)70189-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：807 / 808

页数：2

共 5 条

[1]

ASCHELE C, 2009, P AM SOC CLIN ONTO, V27

[2] Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial [J].

Chua, Yu Jo ;

Barbachano, Yolanda ;

Cunningham, David ;

Oates, Jacqui R. ;

Brown, Gina ;

Wotherspoon, Andrew ;

Tait, Diana ;

Massey, Alison ;

Tebbutt, Niall C. ;

Chau, Ian .

LANCET ONCOLOGY, 2010, 11 (03) :241-248

[3] Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2 [J].

Gerard, Jean-Pierre ;

Azria, David ;

Gourgou-Bourgade, Sophie ;

Martel-Laffay, Isabelle ;

Hennequin, Christophe ;

Etienne, Pierre-Luc ;

Vendrely, Veronique ;

Francois, Eric ;

de La Roche, Guy ;

Bouche, Olivier ;

Mirabel, Xavier ;

Denis, Bernard ;

Mineur, Laurent ;

Berdah, Jean-Francois ;

Mahe, Marc Andre ;

Becouarn, Yves ;

Dupuis, Olivier ;

Lledo, Gerard ;

Montoto-Grillot, Christine ;

Conroy, Thierry .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) :1638-1644

[4]

MAAS M, 2010, LANCET ONCOL, DOI DOI 10.1016/S1420-2045(10)20122-8

[5] Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial [J].

Quirke, Phil ;

Steele, Robert ;

Monson, John ;

Grieve, Robert ;

Khanna, Subhash ;

Couture, Jean ;

O'Callaghan, Chris ;

Myint, Arthur Sun ;

Bessell, Eric ;

Thompson, Lindsay C. ;

Parmar, Mahesh ;

Stephens, Richard J. ;

Sebag-Montefiore, David .

LANCET, 2009, 373 (9666) :821-828

← 1 →